Japan's Rapidus in talks with Apple, Google to mass-produce chips, Nikkei reports-March 2024-www.financetom.com

Japan's Rapidus in talks with Apple, Google to mass-produce chips, Nikkei reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Japan's Rapidus in talks with Apple, Google to mass-produce chips, Nikkei reports

Apr 4, 2025 9:00 AM

April 4 (Reuters) - Japanese chipmaker Rapidus is

negotiating with Apple ( AAPL ), Google and dozens of

other potential clients to mass-produce advanced chips by 2027,

the Nikkei business daily reported on Friday.

(Reporting by Zaheer Kachwala in Bengaluru)

Previous page： X challenges Brazil's 'forced' order to block certain accounts Next page： TSMC says third Arizona fab to begin production by end of decade

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

X challenges Brazil's 'forced' order to block certain accounts

Apr 8, 2024

(Reuters) - X Corp, formerly Twitter, has been forced by court decisions to block certain popular accounts in Brazil and is prohibited from giving details of the order, the company said on Saturday. X owner Elon Musk said in a post on the platform, that this order could lead to a total loss of revenue and shut down of the...

TSMC says third Arizona fab to begin production by end of decade

Apr 8, 2024

TAIPEI, April 8 (Reuters) - Taiwan chipmaker TSMC said on Monday that its third fab in the U.S. state of Arizona is expected to begin production by the end of the decade. ...

Deals of the day-Mergers and acquisitions

Apr 8, 2024

April 8 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Monday: ** Abu Dhabi investor Lunate and Saudi conglomerate Olayan Group have agreed to acquire a 49% stake in ICD Brookfield Place, a major commercial property in Dubai's financial centre. ** French media group Vivendi's Canal+ made an all-cash mandatory offer to buy...

Replimune Group Provides Interim Results for Skin Cancer Therapy

Apr 8, 2024

05:42 AM EDT, 04/08/2024 (MT Newswires) -- Replimune Group ( REPL ) said Sunday that a phase 1/2 clinical trial of its RP1 monotherapy for skin cancer has initially showed an overall response rate of 34.8%. The interim overall response rate comes from eight out of 23 evaluable patients, including five complete and three incomplete responses, the company said. The...